Evidence map›Paper›PMID 30778002›Full record

ReviewThe Indian journal of medical research2018

Cervical cancer screening in rural India: Status & current concepts.

Anand Narain Srivastava, Jata Shankar Misra, Shruti Srivastava, Bhudav C Das, Shilpi Gupta

Open access · diamondAbstract readReview
In one paragraph

Review in The Indian journal of medical research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 133 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Expression of ALDH1A1 & Nanog in squamous cell carcinoma of cervix.The Indian journal of medical research · 2025
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Anand Narain SrivastavaDepartment of Pathology, Era's Lucknow Medical College & Hospital, Era University, Lucknow, India.
Jata Shankar MisraDepartment of Pathology, Era's Lucknow Medical College & Hospital, Era University, Lucknow, India.
Shruti SrivastavaDepartment of Genetics, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, India.
Bhudav C DasAmity Institute of Molecular Medicine & Stem Cell Research, Noida, India.
Shilpi GuptaICMR-National Institute of Cancer and Prevention Research, Noida, India.
Era's Lucknow Medical College and Hospital · INSanjay Gandhi Post Graduate Institute of Medical Sciences · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cervical carcinoma is one of the most common and dreaded diseases of women, and in India, it accounts for 16 per cent of total cervical cancer cases occurring globally. The situation is more alarming in the rural areas where the majority of women are illiterate and ignorant about the hazards of cervical cancer. Different screening strategies such as rural cancer registries and camp approach for cancer detection have been found useful in minimizing the problem of cervical cancer in the villages. Various screening techniques such as visual inspection with acetic acid, visual inspection with Lugol's iodine, visual inspection with magnification devices-magnavisualizer, Pap smear and HPV-DNA testing have been suggested and tried under low-resource settings of our country, and cervical cytology screening has been found effective in reducing incidence of the disease. In the present review, feasibility of different screening methods has been assessed to find out the most suitable mode applicable at the rural level. Single lifetime screening particularly of high-risk women along with analysis of cost-effective tumour markers such as Argyrophilic nucleolar organizer regions (AgNOR) counts to discriminate high-risk dysplasia cases appears to be an appropriate approach in fighting against cervical cancer.

Indexed as

Rural Health ServicesAntigens, NuclearBiomarkers, TumorColoring AgentsDNA, ViralEarly Detection of CancerFemaleGynecological ExaminationHumansIndiaIodidesPapanicolaou TestPapillomaviridaeUterine Cervical NeoplasmsVaginal SmearsAntigens, NuclearBiomarkers, TumorColoring AgentsDNA, ViralIodidesLugol's solutionnucleolar organizer region associated proteinsAgNORcarcinoma cervixrural cervical cancer screeningsingle lifetime cytological screeningsquamous intraepithelial lesion

Identifiers

PMID30778002
PMCPMC6396551
OpenAlexW2913125820

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.